Matches in Wikidata for { <http://www.wikidata.org/entity/Q91984079> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q91984079 description "2019 թվականի դեկտեմբերի 12-ին հրատարակված գիտական հոդված" @default.
- Q91984079 description "article scientifique publié en 2019" @default.
- Q91984079 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91984079 description "scientific article published on 12 December 2019" @default.
- Q91984079 description "wetenschappelijk artikel" @default.
- Q91984079 description "наукова стаття, опублікована 12 грудня 2019" @default.
- Q91984079 name "A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma" @default.
- Q91984079 name "A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma" @default.
- Q91984079 type Item @default.
- Q91984079 label "A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma" @default.
- Q91984079 label "A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma" @default.
- Q91984079 prefLabel "A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma" @default.
- Q91984079 prefLabel "A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma" @default.
- Q91984079 P1433 Q91984079-ACBB770A-D480-4C7A-B3D8-E49906CF08B9 @default.
- Q91984079 P1476 Q91984079-B5E4FDF7-B507-4134-B683-E8CF35026909 @default.
- Q91984079 P2093 Q91984079-326D820D-14CE-4830-855B-D5C6548F767A @default.
- Q91984079 P2093 Q91984079-49E9BE5E-AE8D-411E-8C41-F8F6BAC9F138 @default.
- Q91984079 P2093 Q91984079-5191DF93-5A9B-40F7-A0C9-F514762C0A73 @default.
- Q91984079 P2093 Q91984079-65DF9A67-6028-4F2C-8139-234DDBDB82E4 @default.
- Q91984079 P2093 Q91984079-6CE91034-99F1-4079-B288-2328B0B0F8BC @default.
- Q91984079 P2093 Q91984079-6E534FB9-4159-4CE1-BE0B-2379CBA7E29C @default.
- Q91984079 P2093 Q91984079-7A9C63B1-B17B-483A-8E6E-0B7A7A8D6555 @default.
- Q91984079 P2093 Q91984079-835CC1E4-A1E8-4FFD-87DC-899E5C0593FB @default.
- Q91984079 P2093 Q91984079-85F0EAF7-DF5D-4226-9247-B8931FF00ED7 @default.
- Q91984079 P2093 Q91984079-86FA858B-85ED-487A-B1D6-B2AD1E8A1BD1 @default.
- Q91984079 P2093 Q91984079-8A744008-4FDA-4689-BB1C-5ED6A8002DDF @default.
- Q91984079 P2093 Q91984079-90FF9DC1-1B76-47E6-AF7F-D76403AB2FD6 @default.
- Q91984079 P2093 Q91984079-9423BDDB-6E98-441F-B92F-2F944A733D30 @default.
- Q91984079 P2093 Q91984079-B7111E73-46C8-4FE9-A809-CF5D66C3D44D @default.
- Q91984079 P2093 Q91984079-D83F9D66-63A0-4D2C-97E3-33794FFD61C8 @default.
- Q91984079 P2093 Q91984079-DE36DE42-5DCC-49C2-9605-4866B58E9E8E @default.
- Q91984079 P304 Q91984079-AB13A306-6055-44E6-BB6D-1B508CA5D364 @default.
- Q91984079 P31 Q91984079-2E56370E-20AF-4A98-8098-E82392C20D1F @default.
- Q91984079 P356 Q91984079-94F9BA02-C447-4B24-B61D-867ABD189721 @default.
- Q91984079 P478 Q91984079-F0354393-54E2-4F21-8096-8B651339DDCF @default.
- Q91984079 P577 Q91984079-F293CABB-231F-4733-913F-140B6362504D @default.
- Q91984079 P698 Q91984079-102CB794-2E83-4448-9434-79B1D33A0F49 @default.
- Q91984079 P921 Q91984079-AD643DB8-909C-4D7E-88F1-88A98A1AFEB0 @default.
- Q91984079 P356 J.EJCA.2019.11.007 @default.
- Q91984079 P698 31838406 @default.
- Q91984079 P1433 Q332260 @default.
- Q91984079 P1476 "A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma" @default.
- Q91984079 P2093 "Claudine Schmitt" @default.
- Q91984079 P2093 "Cyril Lervat" @default.
- Q91984079 P2093 "Cécile Dalban" @default.
- Q91984079 P2093 "David Pérol" @default.
- Q91984079 P2093 "Hélène Pacquement" @default.
- Q91984079 P2093 "Jean-Claude Gentet" @default.
- Q91984079 P2093 "Jean-Yves Blay" @default.
- Q91984079 P2093 "Laurence Brugieres" @default.
- Q91984079 P2093 "Marie-Dominique Tabone" @default.
- Q91984079 P2093 "Marie-Pierre Castex" @default.
- Q91984079 P2093 "Mehdi Brahmi" @default.
- Q91984079 P2093 "Nadège Corradini" @default.
- Q91984079 P2093 "Nathalie Gaspar" @default.
- Q91984079 P2093 "OSII Thiotepa study group of the French Society of Pediatric Cancer - La Société Française des Cancers de l’Enfant (SFCE) and the French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) Networks" @default.
- Q91984079 P2093 "Perrine Marec-Berard" @default.
- Q91984079 P2093 "Séverine Metzger" @default.
- Q91984079 P304 "58-68" @default.
- Q91984079 P31 Q13442814 @default.
- Q91984079 P356 "10.1016/J.EJCA.2019.11.007" @default.
- Q91984079 P478 "125" @default.
- Q91984079 P577 "2019-12-12T00:00:00Z" @default.
- Q91984079 P698 "31838406" @default.
- Q91984079 P921 Q42824440 @default.